Split Influenza Vaccine
Indication and Usage:
It can improve immunity of anti
IV after innoculation this vaccine.And it can use for preventing flu that caused by IV.
Dosage and Administration:
(1) Deltoid muscle intramuscular injection or hypodermic injection.
(2) Pre-innoculation before or during the flu epidemic season.Inoculate one stitch of 0.5ml for adults and children who are beyond three years old;Two stitches for children who are between 6 months to 3 years old, each stitch of 0.25ml and the innoculation interval time is 2 to 4 weeks.
Precaution and Warnings:
1.Not inject intravenously
2.Not to use if people who occur any nervous system reaction after injection.
3.Not to use if there have abnormal substances or sediments which can not joggle to equal, vaccine bottle have crack or label ambiguity.
4.It shall have drugs such as adnephrin in order to deal allergic response for first aid.People who take injection shall rest in the room that he/she taking injection for a while.
1.People who catch fever, acute disease and cold.
2.People who have chronicity disease but it acute episode.
3.People who have history of Guillain-Barre Syndrome.
4.People who have history of hypersensitiveness or hypersensitive on heneggs.
5.Women who are during gestation period.
Storage and Package:
Stored and transported at 2 to 8 degree, avoiding light.
Influenza is an infection of the respiratory tract caused by influenza virus.It involves a combination of respiratory (cough, sore throat) and constitutional (fever, headache, muscle aches) symptoms.In Children, older adults and people with a range of pre-existing medical conditions influenza infections can lead to serious and even life threatening complications.
As the circulating viruses change by mutation infections can occur repeatedly throughout life and protection by vaccination requires annual dosing with updated vaccines.Seasonal vaccination prevents influenza and reduces the impact of epidemics.
Each year in February the WHO makes a decision on the influenza strains to be included in the following winter's vaccine for the Northern Hemisphere, and in September for the Southern Hemisphere.The WHO Collaborating Centers then release suitable primary seed virus to the manufacturers, like Tianyuan.These primary seed viruses currently comprise three influenza virus strains.
In Tianyuan's production facility, each of this strains-one A-H3N2, one A-H1N1, and one B strain-are separately propagated in SPF hens eggs to produce larger amounts of the viruses which serves as source for the production of virus batches on an industrial scale.
The production of YUGANNING starts with the inoculation of the virus into the allantoic fluid of healthy chicken embryos, where it multiplies.After a certain period of incubation the virus is harvested, inactivated and purified using different downstream processing techniques.The purified whole virus is then split, using a detergent and further purified to yield the so-called monobulk.These production steps are applied separately for each of the three vaccine components.
In the last step, the components are blended in the correct proportion, and the mixture is filled into syringes or vials of 0.5 ml for adults and 0.25 ml for children.A syringe or vial contains one dose of trivalent influenza vaccine in the required amount of 15 mcg HA per strain for adults and 7.5 mcg HA for children.
Finally, the vaccine quality is checked and then marketed after approval by the national regulatory authority (SFDA).The product is in compliance with the EU standard.
Tianyuan's influenza vaccine YUGANNING is an inactivated split vaccine, produced on embryonated chicken eggs.The vaccine is manufactured according to the seasonal WHO recommendation for Northern and Southern Hemisphere.The vaccine's quality level is comparable to internationally available vaccines.
Contact Name: Leo.ben
Company Name: Sichuan Kelun Bio-tech Pharmaceutical Co., Ltd.
Tel: 86-28-85597761 or 86-28-85597763
Street Address: No. 1308 Yishu
Huaxiang, No. 33 Of Ximian Qiao
Street, Chengdu, Sichuan, China
Member name: KelunBioPharma
Member Since: 13 January 2009
Total Leads: 21 KelunBioPharma Import Export Business Leads
Business focus: Plasma Blood Products, Dna Products, Vaccines, Bio-chemicals
Verify: Safe Import Export Tips